Preliminary list of Speakers & Topics

* As of August 6, 2017

Stephanie
Amiel
UK

Reversibility of Brain changes in diabetes

S. R.Aravind
India

Evolution of Technologies in India

KatharineBarnardUK

Supporting Healthcare Professionals: Finding the QoL Balance

RichardBergenstalUSA
  • Glucose variability: which measures are clinically meaningful?
  • A crossover study comparing two automated insulin delivery system algorithms in adolescents and young adults with type 1 diabetes
Barbara MurnBerkopecSloveniaAddressing barriers to CGM and CL therapies
SarahBiesterGermanyTrain the trainer: what do clinicians need to understand about CL technology?
BruceBodeUSA

Review of Ultra-rapid acting insulins

JanBolinderSweden

Review of flash glucose monitoring – benefits vs capillary and vs CGM

RiccardoBonfantiItaly

CGM stand-alone in children using multiple daily injections

MarcBretonUSA

Diabetes Technology for type 2 diabetes – Decision tools

Luis EduardoCalliariBrazilDiabetes Technology in Developing Countries
EdaCengizUSA
  • Diabetes Technology in Adolescents and Young Adults
  • New short and long acting insulin analogues and glycemic variability
ManjoChawlaIndia

Use of Insulin Pump therapy in India - The changing perspective

PratikChoudharyUK

Understanding the relationship between diabetes distress and metabolic outcomes

MarkClementsUSA

Machine Learning to Improve T1D Care

SelçukDağdelenTurkey

Glycemic variability vs glucose control in adults

ThomasDanneGermany

Beyond A1c: Consensus on CGM outcomes

EyalDassauUSA

Next generation automated insulin delivery:  On-body Ecosystem for Automated Insulin Delivery in Type 1 Diabetes 

HansDeVriesThe Netherlands
  • Glycation gap: does it exist?
  • Debate on: PUMP V. SENSOR – WHAT IS MORE IMPORTANT? – Sensors
  • Major Outcome studies: The HypoDE Study –  Independent commentary
FrancisDoyle IIIUSA

Dealing with patient and device uncertainty in the artificial pancreas: multi-zones, adaptation, and trust indices

GuidoFreckmannGermany

Major Outcome studies: The HypoDE Study – Study design and execution

SatishGargUSA

Role of Concentrated Insulins in diabetes care

MichalGillonIsrael

Nutrition and Food Technologies - Introduction

DamlaGöksenTurkeyGlycemic variability vs glucose control in children
GeorgeGrunbergerUSA

We have the technology, we have the data, and now what?

RagnarHanasSwedenDiabetes Technology in the <6 year old population

LutzHeinemannGermany

Major Outcome studies: The HypoDE Study –Results

SimonHellerUK

Hypoglycemia and Mortality: a causal relationship?

NorbertHermannsGermany

Major Outcome studies: The HypoDE Study –Patient related outcome

IrlHirschUSA
  • Time in ranges or HbA1c?
  • Cost of Medications Vs. Outcomes: Is there an end?
RomanHovorkaUK

Day and Night Closed-loop in Young People With Type 1 Diabetes (DAN05)

NealKaufmanUSA

Digital self-management support interventions:  Foundational to improving health outcomes

JothydevKesavadevIndia

SMBG and Virtual Consultation DTMS (R): 20 Years' Experience

DavidKlonoffUSA

Trends in digital health for diabetes

BorisKovatchevUSA
  • The International Diabetes Closed Loop (iDCL) Trial
  • Decision Support Systems
AaronKowalskiUSA

The role of patients in increasing access to new treatments

LoriLaffelUSA
  • Aligning patient expectations with automated insulin delivery system: understanding Patients reported outcomes
  • Debate on: Can digital health replace the HCP? – CON
NebojsaLalicSerbia

Insulin pump treatment in type 2 diabetes: impact of insulin resistance and related metabolic parameters

LalanthaLeelarathnaUK

Debate on: PUMP V. SENSOR – WHAT IS MORE IMPORTANT? - Pumps

LaurelMesserUSA
  • Artificial pancreas: Managing expectations, misconceptions and preparing patients for success
  • Practical Issues in School with Diabetes Technology
TimoMüllerGermany

Novel pharmacological approaches to treat obesity and T2 diabetes

RevitalNimriIsrael

Debate on: Can digital health replace the HCP? – PRO

JohnPickupUK

What determines the effectiveness of insulin pump therapy: toward precision diabetes Technology

LorenzoPiemontiItaly

Beta Cell replacement – where are we?

WalterPoriesUSA

The downside to metabolic (bariatric) surgery

EricRenardFrance

Diabetes Technology for type 2 diabetes – Artificial Pancreas

YvesReznikFrance

Diabetes Technology for type 2 diabetes – Insulin pumps

FrancescoRubinoUK

Insulin-independent mechanisms of action of bariatric/metabolic surgery

StevenRussellUSA

Bionic pancreas treats adults with type 1 diabetes

BanshiSabooIndia

CGM & AGP - How to reap it's benefit from busy clinics in India?

AndreaScaramuzzaItaly

Efficacy of an APP to count carbs and beyond to limit the postmeal glucose rise in children with type 1 diabetes

DesmondSchatzUSA

Update on worldwide efforts to prevent type 1 diabetes

EranSegal
Israel

Personalized medicine approaches for treatment of diabetes based on gut microbiota 

JenniferSherrUSA

Patients perspective on closed loop technology

MarkSperlingUSA

Post-transplant diabetes in children and adolescents

Henk HVeezeThe NetherlandsValue Based Health Care / Diabeter Experience   


Keep Me Updated